Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Sales (2016 - 2025)

Historic Return on Sales for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 0.24%.

  • Medifast's Return on Sales fell 2500.0% to 0.24% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.05% for FY2025, which is 500.0% down from last year.
  • Per Medifast's latest filing, its Return on Sales stood at 0.24% for Q4 2025, which was down 2500.0% from 0.03% recorded in Q3 2025.
  • Over the past 5 years, Medifast's Return on Sales peaked at 0.12% during Q1 2021, and registered a low of 0.24% during Q4 2025.
  • Moreover, its 5-year median value for Return on Sales was 0.08% (2022), whereas its average is 0.04%.
  • Over the last 5 years, Medifast's Return on Sales had its largest YoY gain of 700bps in 2025, and its largest YoY loss of -2500bps in 2025.
  • Quarter analysis of 5 years shows Medifast's Return on Sales stood at 0.09% in 2021, then fell by -13bps to 0.08% in 2022, then tumbled by -60bps to 0.03% in 2023, then crashed by -79bps to 0.01% in 2024, then plummeted by -3702bps to 0.24% in 2025.
  • Its Return on Sales stands at 0.24% for Q4 2025, versus 0.03% for Q3 2025 and 0.02% for Q2 2025.